Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Genova
Clinical trial register · Italy

Clinical Trials in Genova, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals21 AstraZeneca20 Eli Lilly and Company13 GlaxoSmithKline12 Bristol-Myers Squibb12
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Genova

483 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Ente Ospedaliero Ospedali Galliera
Observational
100
Genova
2026-12-15
Not yet open
Tracheostomy Practice in Adult Intensive Care Units
NCT07769021Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU)
Royal College of Surgeons, Ireland
Observational
2,500
Genova, Naples, Torino
2026-11-02
Recruiting
AstraZeneca
Phase 3
950
Florence, Genova
2026-09-16
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
90
Ancona, Florence, Genova, Messina, Milan, Roma, Rome, Verona
2026-09-15
Recruiting
Incyte Corporation
Phase 3
426
Bari, Bergamo, Bologna, Catania, Florence, Genova, Meldola, Milan
2026-09-08
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
NCT07587242Muscular Dystrophies, Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy), Muscular Disorders, Atrophic, Muscular Disease
DrugAOC 1044
Avidity Biosciences, Inc.
Phase 3
70
Genova, Milan, Roma
2026-09-01
Not yet open
Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.
NCT07486336Fraily, Abdominal Surgery, Postoperative Cognitive Dysfunction (POCD)
Ente Ospedaliero Ospedali Galliera
Not applicable
100
Genova, Vizzolo Predabissi
2026-09-01
Not yet open
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
NCT07533084Active Aging Individuals Aged 65 and Over, Aging, Mild Cognitive Impairment (MCI), Dementia
Neuromed IRCCS
Observational
265
Brescia, Genova, Pozzilli, Milan, Pavia, Roma, Venezia
2026-09
Not yet open
Eli Lilly and Company
Phase 3
170
Ancona, Florence, Genova, Messina, Milan, Naples, Verona
2026-09
Not yet open
PRL2019 in the Treatment of Juvenile Fibromyalgia
NCT07738926Fibromyalgia, Fibromyalgia Syndrome
Istituto Giannina Gaslini
Not applicable
30
Genova
2026-08-01
Recruiting
Boehringer Ingelheim
Phase 3
35
Genova, Roma
2026-07-21
Recruiting
UCB BIOSCIENCES, Inc.
Phase 3
200
Genova, Milan, Naples, Pisa, Troina
2026-07-14
Recruiting
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490Liver Transplantation (LT), Ischemia-Reperfusion Injury, Early Allograft Dysfunction
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Not applicable
170
Ancona, Bari, Bergamo, Bologna, Genova, Modena, Padova, Palermo
2026-07-07
Recruiting
COLON ERDERLY LOW DOSE
NCT06840977Colon Adenocarcinoma
Matteo Clavarezza
Observational
51
Genova, Genoa
2026-07-07
Not yet open
Ente Ospedaliero Ospedali Galliera
Not applicable
147
Genova
2026-07-01
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Aviano, Bergamo, Carpi, Crema, Florence, Genova, Lecco, Meldola
2026-06-26
Recruiting
AstraZeneca
Phase 3
150
Aviano, Bergamo, Genova, Milan, Naples
2026-06-15
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Not yet open
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT07627594Interstitial Lung Disease (ILD), Bronchoscopy, Bronchoalveolar Lavage (BAL), Acute Exacerbation
University of Milan
Observational
427
Milan, Bologna, Genova, Legnano, Modena, Monza, Naples, Siena
2026-06-01
Recruiting
Bayer
Phase 3
117
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2026-06-01
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
144
Bari, Bologna, Meldola, Foggia, Florence, Genova, Province of Macerata, Milan
2026-06
Recruiting
Alfasigma S.p.A.
Phase 3
65
Genova
2026-05-21
Recruiting
Incyte Corporation
Phase 2
60
Bologna, Genova, Monza, Padua, Pavia, Rome
2026-05-20
Recruiting
Ipsen
Phase 3
350
Genova, Milan, Modena, Monza, Novara, Padova, Roma, Rozzano
2026-05-14
Recruiting
Eli Lilly and Company
Phase 2
600
Genova, Milan, Misterbianco, Prato, Roma
2026-05-13
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Not yet open
AI-Assisted Endoscopy for Upper Aerodigestive Tract Lesions
NCT07596355Upper Aerodigestive Tract Neoplasms, Upper AerodigestiveTract Cancer, Upper Aero-digestive Tract (UADT) Neoplasm, Squamous Cell Carcinoma
Istituto Italiano di Tecnologia
Observational
283
Genova
2026-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Rozzano, Orbassano, Verona, Arezzo, Genova, Milan, Roma
2026-04-23
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Bologna, Bolzano, Genova, Milan, Roma, Rozzano, Torino
2026-04-21
Recruiting
BioMarin Pharmaceutical
Phase 2/3
160
Genova, Milan
2026-04-20
Recruiting
Universita degli Studi di Genova
Not applicable
90
Genova
2026-04-10
Recruiting
University of Turin, Italy
Not applicable
820
Rozzano, Bologna, Florence, Foggia, Genova, Milan, Modena, Naples
2026-03-30
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Genova, Pavia, Perugia, Rome, San Raffaele
2026-03-17
Recruiting
Bristol-Myers Squibb
Phase 3
750
Ferrara (Cona), Aviano, Catania, Candiolo, Genova, Milan, Naples, Novara
2026-03-12
Recruiting
Uppsala University
Observational
2,000
Genova
2026-03-01
Not yet open
Istituto Giannina Gaslini
Phase 4
100
Genova
2026-03-01
Not yet open
303 Pharma s.r.l.
Not applicable
20
Genova
2026-03
Recruiting
argenx
Observational
100
Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova
2026-02-25
Recruiting
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
NCT07204990Endotracheal Extubation, Airway Anesthesia, Paediatric
Telethon Kids Institute
Not applicable
1,400
Genova
2026-02-06
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
270
Arezzo, Aviano, Bologna, Brescia, Catania, Cuneo, Florence, Genova
2026-01-31
Recruiting
Novartis Pharmaceuticals
Observational
50
Alessandria, Avellino, Brescia, Florence, Genova, Milan, Palermo, Roma
2026-01-13
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Acireale, Cagliari, Florence, Foggia, Genova, Merano, Naples, Sassari
2026-01-08
Recruiting
Istituto Giannina Gaslini
Not applicable
150
Genova
2026-01-01
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Ancona, Cuneo, Florence, Genova, Legnano, Meldola, Milan, Reggio
2025-12-23
Recruiting
Istituto Giannina Gaslini
Not applicable
60
Genova
2025-12-23
Recruiting
Eli Lilly and Company
Phase 3
800
Bergamo, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Monza
2025-12-22
Recruiting
Novo Nordisk A/S
Phase 3
332
Rome, Bergamo, Messina, Rivoli, Genova, Novara, Orbassano, San Donato Milanese
2025-12-18
Recruiting
UNICANCER
Phase 3
3,902
Aviano, Caserta, Genova, Naples, Padova, Pisa, Pontedera, Roma
2025-12-18
Recruiting
Novartis Pharmaceuticals
Observational
250
Ancona, Bari, Brescia, Cona, Florence, Genova, Lecce, Messina
2025-12-17
Recruiting
Ascendis Pharma A/S
Phase 3
186
Florence, Genova, Naples, Trieste
2025-12-12
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Genova, Milan, Rozzano, Modena, Padova, Palermo, Naples, Roma
2025-12-11
Recruiting
ALX Oncology Inc.
Phase 2
120
Torrette, Genova, Bergamo, Bologna, Milan, Monza, Novara
2025-12-10
Recruiting
Boehringer Ingelheim
Phase 3
120
Genova, Milan, Padova, Roma
2025-12-09
Recruiting
GlaxoSmithKline
Phase 3
450
Meldola, Rozzano MI, Bari, Bologna, Candiolo, Genova, Milan, Padova
2025-12-03
Not yet open
Emanuele Barabino
Observational
250
Genova
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Recruiting
Debiopharm International SA
Phase 3
119
Ferrara, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-26
Not yet open
University of Padova
Observational
172
Bologna, Genova, Torino
2025-11-25
Active, closed
Bayer
Phase 2
60
Bologna, Brescia, Genova, Roma
2025-11-19
Recruiting
Bayer
Phase 3
111
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-19
Recruiting
Summit Therapeutics
Phase 3
600
Roma, Aviano, Brescia, Florence, Genova, Meldola, Milan, Pisa
2025-11-18
Recruiting
Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device
NCT07092436Congenital and Acquired Neuromotor Disorders, Developmental Coordination Disorder (DCD)
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
54
Bosisio Parini, Calambrone, Salerno, Genova, Milan, Pavia
2025-11-17
Recruiting
Novartis Pharmaceuticals
Phase 2
30
Florence, Genova, Roma
2025-11-03
Recruiting
Novartis Pharmaceuticals
Phase 3
12
Genova
2025-10-28
Recruiting
Daiichi Sankyo
Phase 3
686
Bologna, Candiolo, Fano, Genova, Livorno, Milan, Misterbianco, Orbassano
2025-10-24
Recruiting
Gesynta Pharma AB
Phase 2
190
Genova
2025-10-15
Active, closed
A New Crowding Indicator in the Emergency Department
NCT07111624Emergency Department, Crowding
Mario Negri Institute for Pharmacological Research
Observational
828
Brescia, Genova, Ravenna, Roma, Cirié, Orbassano, Vercelli, Alessandria
2025-10-15
Recruiting
Bristol-Myers Squibb
Phase 3
424
Milan, Pisa, Siena, Ancona, Genova
2025-10-08
Recruiting
Rehabilitation Practices in Critically Ill Patients Receiving Invasive Mechanical Ventilation in the Intensive Care Unit.
NCT07093125Mechanical Ventilation, Pulmonary Rehabilitation, Intensive Care Units (ICUs), Quality of Life (QOL)
Universita degli Studi di Genova
Observational
2,400
Genova
2025-10-01
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsRuxolitinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Recruiting
Andrea DeCensi
Phase 2
140
Genova
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsDasatinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Not yet open
Fondazione Don Carlo Gnocchi ETS
Not applicable
50
Genova, Milan
2025-10
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Bari, Genova, Naples, Pavia
2025-09-30
Recruiting
Pfizer
Phase 3
680
Aviano, Rome, Roma, Florence, Verona, Bergamo, Caserta, Genova
2025-09-29
Recruiting
Laboratoires Thea
Observational
200
Bologna, Catania, Corigliano, Genova, Lecce, Lucca, Modena, Morrovalle
2025-09-19
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Genova, Milan, Modena, Naples, Brescia
2025-09-17
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Gussago, Trieste, Bologna, Genova, Milan, Pavia
2025-09-16
Recruiting
Barriers Limiting OCT Penetration in Clinical Practice
NCT07193693Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Consorzio Futuro in Ricerca
Observational
1,000
Bergamo, Genova
2025-09-15
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Bergamo, Brescia, Genova, Milan, Naples, Roma, Sanatorio San Luigi, Udine
2025-09-10
Recruiting
AbbVie
Observational
700
L’Aquila, Milan, Naples, Rome, Genova
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Florence, Genova, Milan, Naples, Padua, Perugia, Rome, Rozzano
2025-09-08
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Arzignano, Baggiovara, Bologna, Caserta, Ferrara, Ferrara (Cona), Florence, Genova
2025-09-02
Not yet open
Fondazione IRCCS San Gerardo dei Tintori
Not applicable
106
Brescia, Monza, Bergamo, Como, Genova, Milan, Padova, Parma
2025-09-01
Not yet open
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
NCT07046663Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Fondazione Italiana Linfomi - ETS
Observational
190
Ancona, Bergamo, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-09
Recruiting
BeOne Medicines
Phase 3
351
Genova, Milan, Pisa, Rozzano
2025-08-27
Recruiting
Basilea Pharmaceutica
Phase 3
234
Genova, Milan, Modena, Pavia, Pisa, Trieste
2025-08-26
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
50
Bari, Meldola, Ferrara, Genova, Lido di Camaiore, Lucca, Monza, Milan
2025-08-12
Recruiting
GlaxoSmithKline
Phase 3
420
Milan, Bergamo, Genova, Orbassano, Pisa, Siena, Verona
2025-08-11
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2
21
Brescia, Florence, Genova, Milan, Padova, Parma
2025-08-07
Recruiting
Intergruppo Melanoma Italiano
Observational
270
Bari, Genova, Milan, Modena, Naples, Padova, Perugia, Roma
2025-08-04
Recruiting
CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
NCT07468461Camptodactyly, Arthropathy, Coxa Vara, Pericarditis
Meyer Children's Hospital IRCCS
Observational
15
Bari, Florence, Genova, Milan, Padova, Roma, Udine
2025-08-01
Recruiting
Istituto Superiore di Sanità
Not applicable
421
Genova
2025-07-31
Recruiting
BioMarin Pharmaceutical
Phase 2
60
Roma, Genova
2025-07-30
Recruiting
Celcuity Inc
Phase 3
1,180
Fano, Genova, Meldola, Milan, Modena, Naples, Parma, Pavia
2025-07-24
Recruiting
Bristol-Myers Squibb
Phase 3
450
Milan, Pisa, Siena, Ancona, Genova
2025-07-18
Recruiting
A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic Repair
NCT07734584Type B Acute Aortic Syndrome, Thoracic and Thoracoabdominal Aneurysms With Crawford Extent I, II, III, or IV
University of Bologna
Not applicable
90
Bologna, Brescia, Genova, Padova
2025-07-15
Recruiting
Repurposing Mirtazapine in Rett Syndrome
NCT07430046RETT Syndrome With Proven MECP2 Mutation
DrugMirtazapine
University of Trieste
Phase 2
54
Genova, Messina, Milan, Siena
2025-07-09
Active, closed
REal-life ON PARKinson's - ITaly (REONPARK-IT)
NCT07403799Parkinson Disease
Bial - Portela C S.A.
Observational
200
Bari, Brescia, Cagliari, Catanzaro, Chieti, Genova, Messina, Milan
2025-07-08
Active, closed
Novartis Pharmaceuticals
Phase 2
138
Genova, Roma
2025-07-03
Recruiting
Devintec Sagl
Not applicable
208
Genova, Milan, Naples, Padova, Roma, Rozzano (MI), Torino
2025-07-02
Recruiting
Universita degli Studi di Genova
Not applicable
80
Genova
2025-07-01
Recruiting
Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients- LIMIT-TBI Trial
NCT07625995Traumatic Brain Injury, Severe Traumatic Brain Injury, Acute Brain Injury, Neurocritical Care
Erasme University Hospital
Phase 2
88
Genova, Roma
2025-07-01
Recruiting
MedSIR
Phase 2
200
Ancona, Aviano, Florence, Genova, Milan, Modena, Monza, Naples
2025-06-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Monza, Livorno, Ancona, Bergamo, Genova, Milan, Pisa, Reggio Emilia
2025-06-30
Active, closed
Mundipharma Research Limited
Phase 2
60
Genova, Pisa, Roma, Rozzano
2025-06-30
Recruiting
GlaxoSmithKline
Phase 3
961
Castelvenere, Foggia, Roma, Catania, Ferrara, Genova, Rozzano
2025-06-23
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bergamo, Foggia, Genova, Milan, Pavia, Roma
2025-06-23
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
36
Genova, Roma, Torino
2025-06-14
Recruiting
Bristol-Myers Squibb
Phase 3
274
Milan, Pisa, Siena, Ancona, Genova
2025-06-13
Recruiting
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NCT07516964Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, Focal Segmental Glomerulosclerosis (FSGS), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
Meyer Children's Hospital IRCCS
Not applicable
50
Bagno a Ripoli, Florence, Bologna, Genova, Parma, Pisa, Prato, Reggio Emilia
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Ancona, Bologna, Catania, Genova, Messina, Milan, Monza (MB), Naples
2025-06-09
Active, closed
Incyte Corporation
Phase 3
9
Alessandria, Ancona, Bergamo, Bologna, Brescia, Catania, Florence, Genova
2025-06-04
Recruiting
Stoke Therapeutics, Inc
Phase 3
170
Florence, Genova, Roma
2025-06-04
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
100
Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Genova, Messina
2025-06-01
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Orbassano, Bari, Bologna, Cagliari, Cuneo, Ferrara, Florence, Genova
2025-06-01
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Cona, Genova, Milan, Rozzano, Pisa, Roma
2025-05-30
Recruiting
High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project
NCT06822231Critical Illness Myopathy, Guillain Barré Syndrome, Critical Illness Polyneuromyopathy (CIPNM)
Istituti Clinici Scientifici Maugeri SpA
Not applicable
124
Bari, Genova, Milan, Modena, Montescano, Pavia, Roma, Telese Terme
2025-05-28
Recruiting
Intelligent Lung Support in the Intensive Care Unit
NCT06595602Mechanical Ventilation, Intensive Care Medicine
Technische Universität Dresden
Observational
530
Genova
2025-05-25
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
160
Acerenza, Bari, Genova, Messina, Milan, Montescano, Pavia, Rome
2025-05-20
Recruiting
Validity of ICU Clinician's Appraisal of Proportionality in CPR
NCT07026773Cardiac Arrest, Out-Of-Hospital
University Hospital, Ghent
Observational
1,000
Genova
2025-05-18
Recruiting
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
NCT07348263Eosinophilic Fasciitis
Meyer Children's Hospital IRCCS
Observational
20
Florence, Genova, Udine
2025-05-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Milan, Verona, Bologna, Genova, Pavia, Roma, Sassari
2025-05-12
Recruiting
Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06916195Cytomegalovirus Infection, Hematopoietic Stem Cells Transplantation
MSD Italia S.r.l.
Observational
230
Genova, Monza, Padova, Roma, Torino
2025-05-09
Recruiting
Takeda
Phase 3
59
Milan, Rozzano, Orbassano, Brescia, Genova, Messina, Pavia, Pisa
2025-05-06
Recruiting
High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
NCT06881979Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Neuropathy, Charcot-Marie-Tooth Disease
Istituti Clinici Scientifici Maugeri SpA
Not applicable
60
Genova, Milan, Modena, Montescano, Pavia, Roma, Telese Terme
2025-04-28
Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993Pneumonia Childhood, Pneumonia, Lung Ultrasound, Antibiotic Stewardship
Meyer Children's Hospital IRCCS
Not applicable
659
Florence, Bergamo, Bologna, Brescia, Genova, Milan, Naples, Novara
2025-04-24
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Bari, Meldola, Naples, Orbassano, Rome, Florence, Genova, Padova
2025-04-24
Recruiting
BioNTech SE
Phase 1/2
380
Bologna, Genova, Milan, Naples, Roma
2025-04-23
Active, closed
Racial Disparities in Acute Stroke
NCT06955442Ischemic Stroke
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
4,500
Bologna, Crema, Frosinone, Genova, Lecce, Naples, Pavia, Pozzilli
2025-04-03
Recruiting
PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
NCT07089550PSMA Positive Tumors or Tumor Tissues, Prostate Cancer Metastatic
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,300
Bologna, Cuneo, Genova, Messina
2025-04-02
By invitation
Neuro-modulation of Central Pain Pathways in Non Inflammatory Musculoskeletal Pain Syndrome
NCT07785362Pain Syndrome, Fibromyalgia, CRPS (Complex Regional Pain Syndromes), Neuromodulation
Istituto Giannina Gaslini
Not applicable
46
Genova
2025-03-31
Not yet open
Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.
NCT06515080General Anesthetic Drug Adverse Reaction
Uppsala University
Observational
500
Genova
2025-03-31
Recruiting
Eli Lilly and Company
Phase 3
700
Bari, Catania, Genova, Meldola, Milan, Monza, Naples, Orbassano
2025-03-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Rome, Bologna, Genova, Milan, Novara, Padova, Roma
2025-03-16
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Milan, Rozzano, Turin, Bologna, Genova, Udine
2025-03-12
Recruiting
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
NCT06856902Cardiovascular Diseases, Endocrinology, Inmunology, Neurology
Technical University of Madrid
Not applicable
3,100
Genova
2025-03-01
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Bologna, Genova, Palermo, Pescara, Perugia, Ravenna, Roma, Torino
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Catania, Florenze, Genova, Milan, Modena, Naples, Padova, Pisa
2025-02-27
Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS
Observational
400
Ancona, Bari, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-02-27
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Alessandria, Bari, Bologna, Florence, Genova, Messina, Milan, Modena
2025-02-26
Recruiting
Istituto Clinico Humanitas
Observational
300
Benevento, Bergamo, Brindisi, Brescia, Campobasso, Florence, Genova, Messina
2025-02-25
Active, closed
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
DrugCannabidiol
Jazz Pharmaceuticals
Observational
111
Bologna, Catanzaro, Chieti, Florence, Genova, Messina, Milan, Naples
2025-02-24
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Genova, Milan
2025-02-24
Active, closed
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865Aneurysm, Dissection, Aortic, TAA Thoracoabdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
W.L.Gore & Associates
Observational
155
Bologna, Brescia, Cagliari, Genova, Padova
2025-02-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna, Bari, Cagliari, Catania, Catanzaro, Florence, Genova, Messina
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Bergamo, Bologna, Genova, Gussago, Milan, Modena, Monza, Pavia
2025-02-10
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Ancona, Bari, Bologna, Genova, Milan, Modena, Naples, Padova
2025-02-04
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Bologna, Genova, Milan, Naples, Padova
2025-02-03
Recruiting
Università Vita-Salute San Raffaele
Not applicable
400
Catanzaro, Florence, Genova, Milan, Monza, Naples, Padova, Udine
2025-01-30
Recruiting
Landiolol in Mitral Valve Surgery
NCT06793670Cardiac Failure, Low Cardiac Output Syndrome
DrugLandiolol
Università Vita-Salute San Raffaele
Phase 4
1,500
Alessandria, Torino, Catania, Florence, Foggia, Genova, Milan, Palermo
2025-01-28
Recruiting
Fondazione Oncotech
Phase 2
51
Catania, Genova, Naples, Padova, Aviano, Roma
2025-01-27
Recruiting
IRCCS Policlinico S. Donato
Not applicable
30,000
Milan, Ancona, Genova, Naples, Palermo, Pavia, Pozzilli, Rome
2025-01-22
Recruiting
Incyte Corporation
Phase 3
240
Alessandria, Ancona, Bari, Brescia, Catania, Genova, Milan, Naples
2025-01-21
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
400
Bergamo, Bologna, Genova, Milan, Padova, Palermo, Pavia, Roma
2025-01-10
Active, closed
Daiichi Sankyo
Phase 2
335
Catania, Genova, Meldola, Milan, Naples, Terni
2025-01-06
Active, closed
mAbxience Research S.L.
Phase 3
726
Brescia, Cremona, Genova, Lecce, Meldola, Pavia, Roma, Siena
2024-12-30
Recruiting
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
250
Brescia, Genova, Milan, San Donato Milanese
2024-12-24
Active, closed
argenx
Phase 3
154
Florence, Genova, Gussago, Messina, Milan, Roma, Rozzano
2024-12-18
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Bologna, Cagliari, Genova, Milan, Naples, Pisa, Roma, Siena
2024-12-17
Recruiting
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
NCT06771193Cervical Cancer, Locally Advanced Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer
MSD Italia S.r.l.
Observational
200
Bologna, Catania, Genova, Milan, Modena, Naples, Aviano, Roma
2024-12-17
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Genova, Milan
2024-12-12
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Brescia, Catania, Genova, Milan, Palermo, San Donato Milanese, Torino, Verona
2024-12-12
Active, closed
Amgen
Phase 3
707
Foggia, Gallipoli, Genova, Milan, Orbassano, Trento
2024-12-09
Active, closed
PPM Services S.A.
Phase 3
400
Ancona, Florence, Genova, Parma, Pavia, Roma, Bologna, Catania
2024-12-05
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Bergamo, Cagliari, Florence, Genova, Livorno, Milan, Modena, Monza
2024-12-05
Recruiting
OSE Immunotherapeutics
Phase 3
363
Meldola, San Filippo, Rozzano, Naples, Orbassano, Legnago, Genova, Lecce
2024-12-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Bologna, Genova, Milan, Pisa
2024-12-02
Recruiting
Anna Estraneo
Not applicable
118
Sant'Angelo dei Lombardi, Bari, Telese Terme, Genova, Milan, Pavia
2024-12-02
Not yet open
University of Genova
Observational
26
Genova
2024-12-01
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Florence, Genova, Roma
2024-11-22
Recruiting
UCB Biopharma SRL
Phase 3
450
Brescia, Genova, Milan, Padova, Pisa, Roma, Rozzano
2024-11-21
Recruiting
Takeda
Phase 3
30
Genova, Messina, Naples, Rome, Trieste
2024-11-19
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
100
Bari, Florence, Genova, Milan, Salerno
2024-11-18
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
300
Bari, Bologna, Cagliari, Ferrara, Florence, Foggia, Genova, Messina
2024-11-04
Recruiting
IRCCS Fondazione Stella Maris
Not applicable
194
Genova, Bosisio Parini, Milan, Pavia, Calambrone, Salerno
2024-11-04
Recruiting
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
NCT06380530Musculoskeletal Deformity, Musculoskeletal Abnormalities, Musculoskeletal Disorder
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna, Rozzano, Genova, Milan, Pavia, Roma
2024-10-31
Recruiting
Istituto Ortopedico Rizzoli
Observational
1,000
Bologna, Genova, Milan, Pavia, Roma, Rozzano
2024-10-31
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Genova, Pavia, Naples, Palermo, Roma
2024-10-29
Recruiting
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NCT06685744Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS
Not applicable
300
Bari, Genova, Lecco, Milan, Modena, Pavia
2024-10-23
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Biella, Brescia, Genova, Milan, Rozzano, Novara, Parma, Perugia
2024-10-22
Recruiting
BioMarin Pharmaceutical
Phase 2
100
Florence, Roma, Genova
2024-10-21
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bari, Bologna, Genova, Milan, Padova
2024-10-05
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT06804421Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori
Observational
1,400
Bergamo, Bologna, Brescia, San Fermo della Battaglia, Cremona, Florence, Genova, Lecco
2024-09-28
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Ferrara, Genova, Milan, Pisa, Roma, Torino, Verona
2024-09-17
Active, closed
GlaxoSmithKline
Phase 2
153
Genova, Milan, Naples, Roma, Sassari
2024-09-17
Recruiting
Consorzio Oncotech
Observational
300
Bari, Bologna, Cuneo, Catania, Meldola, Florence, Genova, Monza
2024-09-13
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
Angela Toss
Observational
100
Genova, Milan, Modena, Padova, Roma
2024-09-05
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
By invitation
Giovanni Di Perri
Observational
200
Genova, Milan, Torino, Bari, Catania, Naples, Padova, Roma
2024-09-02
Recruiting
Ospedale Policlinico San Martino
Not applicable
80
Genova
2024-09-02
Recruiting
San Luigi Gonzaga Hospital
Not applicable
360
Aosta, Biella, Cuneo, Cona, Genova, Rivoli, Trapani, Orbassano
2024-09-01
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Bari, Genova, Modena, Pavia, Rome
2024-08-30
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
596
Acerenza, Bari, Bergamo, Catania, Catanzaro, Crotone, Foggia, Genova
2024-08-12
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Bologna, Genova, Milan, Mirano, Pavia, Reggio Emilia, Terni
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Bologna, Florence, Genova, Milan, Palermo, Roma, Orbassano
2024-07-31
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Recruiting
GlaxoSmithKline
Phase 3
150
Catania, Genova, Roma, Rozzano
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Genova, Milan, Padova, Rozzano, Salerno, San Donato Milanese, Torino
2024-07-19
Recruiting
Amgen
Phase 3
450
Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola FC, Milan, Naples
2024-07-17
Recruiting
Fondazione Oncotech
Observational
300
Avellino, Ancona, Aviano, Bari, Barletta, Bergamo, Caserta, Genova
2024-07-01
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Bologna, Brindisi, Brescia, Cuneo, Como, Cremona, Ferrara, Genova
2024-06-28
Recruiting
argenx
Phase 2/3
12
Genova
2024-06-28
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Alessandria, Bologna, Catania, Cuneo, Ferrara, Florence, Genova, Milan
2024-06-26
Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383Non-small Cell Lung Cancer, NSCLC, NSCLC, Stage III, NSCLC, Stage I
MSD Italia S.r.l.
Observational
600
San Giovanni Rotondo, Brescia, Campobasso, Catania, Florence, Genova, Messina, Milan
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Bergamo, Bologna, Genova, Milan, Pavia, Rome, Treviso
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bergamo, Foggia, Genova, Naples, Pavia, Roma, Rozzano
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Recruiting
X4 Pharmaceuticals
Phase 3
176
Torrette, Brescia, Genova, Meldola, Monza, Roma, Torino
2024-06-06
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Florence, Genova, Milan, Padova, Roma, Trieste
2024-05-28
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Cefalù, Genova, Palermo, Roma, Tricase
2024-05-24
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Recruiting
NMD Pharma A/S
Phase 2
84
Bergamo, Bologna, Genova, Milan, Naples, Pisa, Roma
2024-05-16
Active, closed
European Myeloma Network B.V.
Phase 2
50
Bari, Bergamo, Florence, Genova, Meldola, Novara, Padova, Pavia
2024-05-14
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Bari, Genova, Milan, Monza, Padova
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Milan, Orbassano, Torino, Bologna, Genova, Meldola, Novara, Pavia
2024-04-22
Active, closed
Amgen
Phase 3
111
Genova, Verona
2024-04-22
Active, closed
Bristol-Myers Squibb
Phase 3
44
Florence, Genova, Naples
2024-04-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Meldola, Aviano, Milan, Rozzano, Bologna, Genova, Roma
2024-04-14
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Caserta, Florence, Genova, Grosseto, Monza, Milan, Piacenza, Gubbio
2024-04-11
By invitation
Istituto Italiano di Tecnologia
Observational
40
Genova
2024-04-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Misterbianco, Meldola, Milan, Monza, Rome, Florence, Bergamo, Genova
2024-04-03
Recruiting
Italian Sarcoma Group
Observational
250
Rozzano, Aviano, Orbassano, Bari, Bologna, Florence, Genova, Milan
2024-03-29
Active, closed
GlaxoSmithKline
Phase 4
336
Genova, Monserrato CA, Naples, Pieve Di Soligo TV, Roma, Rozzano, Verona
2024-03-20
Recruiting
Umbria Bioengineering Technologies
Not applicable
10,000
Genova, Foligno, Trieste
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Florence, Genova, Milan, Padova, Roma
2024-03-14
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Brescia, Cona, Genova, Milan, Rozzano, Pisa, Roma, Negrar
2024-03-12
Active, closed
Eli Lilly and Company
Phase 3
17,300
Arzignano, Baggiovara, Bologna, Cinisello Balsamo, Ferrara, Florence, Genova, Milan
2024-03-05
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Bergamo, Genova, Naples, Verona
2024-02-26
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Meldola (Fc), Milan, Monza, Genova, Brescia, Roma, Ancona, Aviano (PN)
2024-02-21
Recruiting
Genexine, Inc.
Phase 3
429
Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
2024-01-25
Active, closed
BicycleTx Limited
Phase 2
375
Aviano, Genova, Naples
2024-01-24
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Recruiting
Colorado Prevention Center
Phase 3
5,200
Bergamo, Catanzaro, Genova, Varese, Ancona, Brescia
2024-01-17
Recruiting
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NCT06356727Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
Azienda Ospedaliera Universitaria Integrata Verona
Not applicable
190
Ferrara, Genova, Milan, Naples, Roma, Rome, Torino, Verona
2024-01-03
Active, closed
Novartis Pharmaceuticals
Phase 2
49
Genova, Milan, Roma, Naples
2024-01-03
Recruiting
Daiichi Sankyo
Phase 3
250
Bari, Bologna, Genova, Milan, Misterbianco, Naples, Padova, Prato
2023-12-30
Recruiting
EXO Biologics S.A.
Phase 1/2
265
Florence, Genova, Milan, Modena, Padua
2023-12-28
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Bari, Genova, Milan, Monza, Padova
2023-12-28
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Aviano, Brescia, Cona, Genova, Lecce, Meldola, Milan, Padova
2023-12-20
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
285
Meldola, Genova, Milan, Modena, Pavia, Ravenna, Roma, Verona
2023-12-18
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Aviano, Bergamo, Cattolica, Florence, Genova, Guastalla, Lecco, Legnano
2023-12-15
Recruiting
Intellia Therapeutics
Phase 3
1,200
Bologna, Cona, Florence, Genova, Pavia, Pisa, Trieste
2023-12-13
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Castellana Grotte, Catania, Florence, Genova, Milan, Modena, Naples, Pisa
2023-12-05
Recruiting
Thomas Riva
Not applicable
1,192
Genova
2023-12-01
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsTrametinib·Cytarabine·Dexamethasone·Cyclophosphamide
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Recruiting
Summit Therapeutics
Phase 3
1,600
Ancona, Aviano, Cremona, Genova, Lucca, Mantua, Milan, Monza
2023-10-26
Recruiting
Ospedale Policlinico San Martino
Not applicable
112
Genova
2023-10-25
Recruiting
Ospedale Policlinico San Martino
Observational
96
Genova
2023-10-10
Recruiting
dr. M.J.N.L. Benders
Observational
1,000
Florence, Genova, Milan, Pisa
2023-10-06
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Tricase, Milan, Meldola, Borgo Roma, Alessandria, Genova, Parma, Pavia
2023-10-04
Recruiting
Deciphera Pharmaceuticals, LLC
Phase 1/2
94
Florence, Genova, Milan
2023-09-28
By invitation
Sarepta Therapeutics, Inc.
Phase 3
400
Genova, Milan, Roma
2023-09-27
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
654
Alessandria, Biella, Brescia, Catania, Cuneo, Florence, Genova, Meldola
2023-09-19
Recruiting
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
NCT05926505Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID
DrugAnakinra
Hellenic Institute for the Study of Sepsis
Phase 2/3
182
Genova, Jesolo, Milan, Modena, Rome
2023-09-06
Recruiting
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
NCT05689619Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer
A.O.U. Città della Salute e della Scienza
Not applicable
70
Genova, Messina, Rome, Turin
2023-09-01
Recruiting
Fondazione Don Carlo Gnocchi ETS
Observational
40
Genova, Milan
2023-09-01
Recruiting
AstraZeneca
Phase 3
231
Genova, Pavia, Roma
2023-08-24
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Genova
2023-08-17
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Genova
2023-08-17
Active, closed
Emalex Biosciences Inc.
Phase 3
150
Genova, Naples, Roma, Catania, Milan
2023-08-16
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
NCT06000943Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Niguarda Hospital
Observational
2,500
Milan, Rozzano, San Donato Milanese, Genova, Potenza, Roma, Torino
2023-08-01
Active, closed
Mineralys Therapeutics Inc.
Phase 3
1,076
Bologna, Ferrara, Genova, Messina, Pisa, Roma
2023-07-14
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, Rozzano, Palermo, Genova, Milan, Modena, Naples, Padova
2023-06-19
Recruiting
Servier Affaires Médicales
Phase 3
245
Meldola, Brescia, Genova, Perugia
2023-06-14
Recruiting
European Aortic Data Collection Project
NCT05896397Complex Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Chronic Aortic Dissection
Cook Research Incorporated
Observational
600
Bologna, Genova, Milan
2023-05-31
Active, closed
Amgen
Phase 3
509
Bergamo, Catanzaro, Genova, Meldola (FC), Orbassano, Roma
2023-05-31
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
148
Genova, Milan, Roma
2023-05-31
Recruiting
Rijnstate Hospital
Not applicable
300
Genova, Bologna
2023-05-26
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
3,500
Aviano, Brescia, Catania, Como, Cremona, Florence, Genova, Meldola
2023-05-01
Recruiting
Consorzio Oncotech
Phase 2
118
Brescia, Candiolo, Catania, Cremona, Florence, Genova, Milan, Modena
2023-04-18
Active, closed
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA
DrugApitegromab
Scholar Rock, Inc.
Phase 3
238
Genova, Messina, Milan, Roma
2023-04-17
Recruiting
AstraZeneca
Phase 3
4,300
Bari, Catania, Catanzaro, Florence, Genova, Grosseto, Milan, Modena
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ancona, Brescia, Caserta, Chieti, Catanzaro, Florence, Chiavari, Genova
2023-03-09
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Active, closed
Novartis Pharmaceuticals
Phase 2
33
Brescia, Florence, Genova, Milan, Roma
2023-02-28
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Milan, Roma, Torino, Bari, Florence, Genova, Naples, Padova
2023-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Recruiting
Tampere University
Not applicable
12,000
Genova, Milan, Rome, Turin
2023-02-01
Recruiting
Umbria Bioengineering Technologies
Not applicable
600
Genova, Foligno, Trieste
2023-01-07
Recruiting
Meyer Children's Hospital IRCCS
Observational
1,000
Florence, Bari, Belluno, Bologna, Genova, Milan, Modena, Naples
2022-12-22
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova
2022-12-21
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Bologna, Genova, Milan, Modena, Naples, Novara, Padova, Pavia
2022-12-16
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Recruiting
Gilead Sciences
Phase 3
1,514
Bari, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Modena
2022-12-12
Active, closed
Bristol-Myers Squibb
Phase 2
189
Genova, Orbassano, Naples
2022-12-09
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
1,000
Aviano, Ancona, Avellino, Brindisi, Catania, Genova, Mantua, Meldola
2022-12-03
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
500
Genova, Messina, Milan, Rome
2022-11-28
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Ancona, Florence, Genova, Messina, Milan, Naples, Orbassano, Potenza
2022-11-23
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Genova, Milan, Monza, Naples
2022-11-11
Recruiting
Bayer
Phase 3
100
Bologna, Florence, Genova, Milan, Roma, Torino
2022-11-08
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Ancona, Florence, Genova, Milan, Orbassano, Potenza, Verona
2022-11-08
Recruiting
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
NCT07146503Depression and Quality of Life, Treatment Resistant Depression (TRD), Anhedonia, Apathy
DrugsIntranasal·Esketamine
Riccardo Guglielmo
Observational
100
Genova, Chieti, Milan, Pavia
2022-11-01
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Genova, Legnago, Pavia, Treviglio, Verona
2022-10-27
Recruiting
The Italian Registry of Malnutrition in Oncology
NCT06337019Cancer, Cancer Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,500
Bari, Castellana Grotte, Bologna, Meldola, Genova, Milan, Aviano, Padova
2022-10-25
Active, closed
Almirall, S.A.
Phase 4
447
Arezzo, Brescia, Genova, Modena, Naples, Reggio Emilia, Roma, Rozzano
2022-10-24
Active, closed
GlaxoSmithKline
Phase 2
351
Avellino, Bergamo, Genova, Pisa, Verona
2022-10-14
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ancona, Bergamo, Bologna, Brindisi, Candiolo, Florence, Genova, Milan
2022-10-04
Recruiting
PedAL BCU, LLC
Phase 3
130
Genova, Monza, Roma, Torino
2022-10-01
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Catania, Genova, Milan, Naples, Orbassano, Pavia, Roma, Rozzano
2022-09-23
Recruiting
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
NCT05601700Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
DrugLetrozole
Ente Ospedaliero Ospedali Galliera
Phase 3
132
Arezzo, Ponderano, Belluno, Brescia, Como, Meldola, Ferrara, Genova
2022-09-22
Active, closed
Biogen
Phase 2/3
450
Bologna, Brescia, Florence, Genova, Milan, Naples, Roma
2022-09-13
Recruiting
AstraZeneca
Phase 2
454
Florence, Genova, Milan, Naples, Rome
2022-09-06
Active, closed
Novo Nordisk A/S
Phase 3
412
Milan, Florence, Genova, Naples, Roma, Rome
2022-08-10
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bergamo, Ferrara, Genova, Milan, Naples, Roma
2022-07-22
Recruiting
Azienda Ospedaliera di Padova
Observational
46
Bologna, Brescia, Florence, Genova, Padova, Roma
2022-07-01
Active, closed
Celgene
Phase 3
939
Rome, Bologna, Catania, Genova, Milan, Novara, Pavia, Pisa
2022-06-23
Recruiting
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374Head and Neck Cancer, Nasopharynx Cancer, Nasal Cavity and Paranasal Sinus Cancer, Salivary Gland Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
13,600
Genova, Milan, Rozzano, Pavia, Prato, Roma
2022-05-31
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
NCT05482945Cardiac Arrest, Out-Of-Hospital, Cardiac Arrest With Successful Resuscitation
Mario Negri Institute for Pharmacological Research
Phase 2
120
Genova, Monza, Milan, Parma, Pordenone, Reggio Emilia, Roma, Trento
2022-05-30
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Bari, Bologna, Genova, Milan, Pavia, Roma, Torino
2022-05-30
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Peschiera del Garda, Cotignola, Genova
2022-05-19
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Florence, Genova, Milan, Monza, Padova, Roma, Trieste
2022-05-19
Active, closed
IO Biotech
Phase 3
407
Ancona, Aviano, Bari, Candiolo, Genova, Meldola, Milan, Naples
2022-05-17
Active, closed
AstraZeneca
Phase 3
644
Borgo San Lorenzo, Catanzaro, Genova, Livorno, Milan, Modena, Naples, Province of Macerata
2022-05-16
Active, closed
Pierre Fabre Medicament
Phase 3
815
Meldola, Taormina, Naples, Aviano, Bari, Bergamo, Cuneo, Genova
2022-05-02
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Bologna, Genova, Pavia, Piacenza
2022-04-05
Recruiting
PET-Guided Resection in High-Grade Gliomas
NCT07567196Glioma Glioblastoma Multiforme, Glioma, High Grade, Glioma Surgery, Positron-Emission Tomography(PET)
Universita degli Studi di Genova
Observational
100
Torino, Genova
2022-04-01
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
DrugAmbisome
F2G Biotech GmbH
Phase 3
225
Naples, Monza, Rozzano, Genova, Milan, Modena, Perugia, Pisa
2022-03-31
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Turin, Florence, Genova, Milan, Pavia, Reggio Emilia, Roma
2022-03-29
Active, closed
Bayer
Phase 3
219
Bologna, Florence, Genova, Milan, Roma, Torino
2022-03-28
Active, closed
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
NCT04769895Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD
MaaT Pharma
Phase 3
66
Ancona, Bologna, Genova, Milan, Reggio Calabria, Roma, Torino, Udine
2022-03-25
Active, closed
W.L.Gore & Associates
Observational
259
Genova, Milan, Roma
2022-03-23
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Recruiting
Amgen
Phase 3
60
Chieti, Genova, Milan, Roma
2022-03-17
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bologna, Brescia, Florence, Genova, Messina, Milan, Naples, Pavia
2022-03-15
Active, closed
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
NCT05064878CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm, Refractory Seizures
DrugFintepla
Zogenix, Inc.
Phase 3
87
Florence, Genova, Modena, Roma, Verona
2022-03-08
Active, closed
AstraZeneca
Phase 3
390
Bari, Catania, Florence, Genova, Milan, Naples, Padova, Parma
2022-02-21
By invitation
UCB Biopharma SRL
Phase 3
300
Genova, Milan, Pavia, Roma
2022-02-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Chieti, Potenza, Caserta, Catanzaro, Cosenza, Bologna, Genova, Bergamo
2022-01-26
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Bari, Bologna, Florence, Foggia, Genova, Messina, Milan, Naples
2022-01-10
Active, closed
Società Italiana Talassemie ed Emoglobinopatie
Observational
1,000
Torino, Cagliari, Ferrara, Genova, Milan, Naples, Palermo, Roma
2022-01-01
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Genova, Monza, Roma, Torino
2021-12-27
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
DrugMitapivat
Agios Pharmaceuticals, Inc.
Phase 3
194
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Bari, Bergamo, Bologna, Florence, Genova, Milan, Rozzano, Palermo
2021-12-17
Recruiting
Takeda
Phase 2
135
Bari, Bologna, Brescia, Florence, Genova, Milan, Reggio Emilia, Roma
2021-12-16
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Recruiting
UCB Biopharma SRL
Phase 3
350
Catanzaro, Genova, Milan, Pavia, Roma
2021-12-07
Recruiting
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
NCT06892223Acute Myeloid Leukaemia, MDS (Myelodysplastic Syndrome), MPN (Myeloproliferative Neoplasms)
DrugMonalizumab
Istituto Clinico Humanitas
Phase 2
42
Genova, Rozzano
2021-12-03
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bologna, Candiolo, Genova, Meldola, Milan, Modena, Reggio Emilia, Rome
2021-12-02
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-11-30
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Perugia, Genova, Milan
2021-11-22
Recruiting
Azienda USL Reggio Emilia - IRCCS
Not applicable
282
Bologna, Genova, Milan, Modena, Reggio Emilia
2021-11-18
Recruiting
Janssen Pharmaceutica N.V., Belgium
Observational
300
Bari, Bologna, Catania, Civitanova Marche, Genova, Lecce, Meldola, Padova
2021-11-18
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Aversa, Brescia, Genova, La Spezia, Milan, Paderno Dugnano, Palermo, Roma
2021-11-16
Active, closed
Amgen
Phase 3
303
Bari, Bergamo, Bologna, Genova, Lecce, Mestre (VE), Milan, Naples
2021-11-02
Recruiting
argenx
Phase 2/3
12
Bari, Florence, Genova
2021-10-26
Active, closed
Camurus AB
Phase 3
332
Bari, Bologna, Brescia, Florence, Genova, Meldola, Milan, Modena
2021-10-22
Recruiting
Niguarda Hospital
Phase 3
288
Ancona, Bergamo, Bologna, Brescia, Cagliari, Chieti, Florence, Genova
2021-10-07
Recruiting
Pfizer
Phase 3
893
Meldola, Milan, Monza, Catania, Bologna, Genova, Roma
2021-10-04
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Roma, Bologna, Genova, Messina, Milan, Naples, Pavia
2021-09-21
Recruiting
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Not applicable
78
Arezzo, Florence, Genova, Milan, Palermo, Perugia, Pistoia
2021-09-14
Recruiting
Amgen
Phase 3
60
Chieti, Genova, Milan, Roma
2021-09-09
Active, closed
Regeneron Pharmaceuticals
Observational
717
Rozzano, Catania, Pisa, Siena, Padova, Catanzaro, Genova, Rome
2021-08-12
Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT05003986Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy, IgA Vasculitis
DrugSparsentan
Travere Therapeutics, Inc.
Phase 2
67
Bari, Genova, Milan, Padova, Roma
2021-08-12
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Active, closed
Bristol-Myers Squibb
Phase 3
670
Genova, Pavia, Udine, Verona
2021-07-13
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bergamo, Brescia, Florence, Genova, Milan, Palermo, Torino, Trieste
2021-07-13
Active, closed
GlaxoSmithKline
Phase 3
40
Ancona, Bologna, Brindisi, Candiolo to, Catania, Genova, Meldola FC, Milan
2021-06-28
Recruiting
Meyer Children's Hospital IRCCS
Observational
300
Florence, Genova
2021-06-15
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893Ewing Sarcoma of Bone
Italian Sarcoma Group
Observational
100
Rozzano, Aviano, Candiolo, Bari, Bologna, Florence, Genova, Milan
2021-06-01
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Bologna, Genova, Milan, Perugia, Turin, Verona
2021-05-21
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Recruiting
MANI Real-life Perspective Observatory
NCT04796844Asthma, Mild Asthma, Moderate Asthma
Societa Italiana di Pneumologia
Observational
20,000
Genova
2021-05-01
Active, closed
AstraZeneca
Phase 3
1,157
Bergamo, Candiolo, Genova, Livorno, Milan, Naples, Padova, Rozzano
2021-04-26
Active, closed
Geron Corporation
Phase 3
327
Alessandria, Bologna, Cona, Florence, Genova, Milan, Ravenna, Reggio Calabria
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Alessandria, Meldola, Ravenna, Milan, Bologna, Genova, Palermo, Potenza
2021-04-08
Active, closed
Kedrion S.p.A.
Phase 3
30
Brescia, Florence, Genova, Milan, Naples, Roma
2021-03-31
Recruiting
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
NCT04847635Macular Degeneration, Senile, Laser Burn of Retina, Macular Degeneration Intermediate, Macular Degeneration, Dry
Ospedale San Raffaele
Not applicable
50
Genova, Milan, Rome
2021-03-16
Recruiting
Fondazione EMN Italy Onlus
Observational
1,900
Florence, Ancona, Bari, Bologna, Brescia, Catania, Genova, Milan
2021-03-16
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Catania, Meldola, Genova, Milan, Monza, Novara, Rionero in Vulture, Roma
2021-03-11
Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, Non-malignant Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Bologna, Brescia, Genova, Milan, Monza, Padova, Pavia, Torino
2021-02-24
Active, closed
Stichting European Myeloma Network
Phase 2
160
Ancona, Bologna, Bolzano, Brescia, Florence, Genova, Pavia, Terni
2021-02-22
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
38
Bari, Florence, Genova, Perugia, Roma, Rozzano
2021-02-12
Active, closed
Galderma R&D
Phase 3
500
Catania, Chieti, Genova, L’Aquila, Modena, Naples, Parma, Perugia
2021-01-11
Active, closed
Stryker Neurovascular
Observational
405
Florence, Genova, Milan, Rome
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
605
Bologna, Catania, Genova, Milan, Orbassano, Roma
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bari, Florence, Genova, Milan, Pisa, Roma, Rome, Torino
2020-12-18
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Milan, Genova, Naples, Pavia
2020-12-11
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Arezzo, Candiolo, Carpi, Catania, Foggia, Genova, Lugo, Milan
2020-12-07
Active, closed
Fondazione Melanoma Onlus
Phase 2
95
Bagno a Ripoli, Meldola, Milan, Naples, Padova, Genova
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
500
Genova, Milan, Padua, Pisa, Candiolo, Orbassano, Torino
2020-10-28
Active, closed
Acerta Pharma BV
Phase 3
611
Bari, Bergamo, Bologna, Florence, Genova, Meldola, Milan, Novara
2020-10-08
Active, closed
University of Zurich
Not applicable
986
Cuneo, Genova, Palermo, Turin
2020-09-30
Active, closed
argenx
Phase 2
229
Brescia, Florence, Genova, Messina, Milan, Pisa, Roma, Torino
2020-09-18
Active, closed
AstraZeneca
Phase 3
866
Aviano, Bergamo, Candiolo, Cona, Genova, Livorno, Messina, Milan
2020-07-24
Recruiting
University of Turin, Italy
Not applicable
416
Grosseto, Sesto San Giovanni, La Spezia, Candiolo, Pinerolo, Bologna, Ferrara, Genova
2020-07-13
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Genova, Rome
2020-07-13
Recruiting
International CIPN Assessment and Validation Study
NCT04633655Chemotherapy-induced Peripheral Neuropathy, Quality of Life
University of Milano Bicocca
Observational
1,000
Monza, Como, Genova, Messina, Padova, Verona
2020-06-08
Recruiting
Società Italiana Talassemie ed Emoglobinopatie
Observational
10,000
Genova
2020-03-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Areezo, Candiolo, Cremona, Genova, Meldola, Milan, Pisa, Terni
2020-03-30
Recruiting
Federico II University
Observational
5,000
Arzignano, Bari, Caserta, Catanzaro, Eboli, Foggia, Genova, Lecce
2020-03-07
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Active, closed
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
NCT04042025Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III, SMA
DrugsOnasemnogene Abeparvovec-xioi·Zolgensma
Novartis Gene Therapies
Phase 3
85
Roma, Genova, Milan
2020-02-10
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Active, closed
Advanced Accelerator Applications
Phase 3
226
Bologna, Genova, Meldola, Milan, Naples, Reggio Emilia, Roma
2020-01-08
Active, closed
Pfizer
Phase 3
1,068
Misterobianco (CT), Cremona, Rozzano, Turin, Reggio Emilia, Arezzo, Bari, Genova
2019-12-30
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Bari, Brescia, Catania, Florence, Genova, Modena, Parma, Pavia
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Florence, Genova, Milan, Roma, Torino
2019-11-04
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
76
Ancona, Ascoli Piceno, Bergamo, Bologna, Bolzano, Brescia, Cuneo, Genova
2019-10-30
Recruiting
GlaxoSmithKline
Phase 1/2
184
Genova, Milan, Padova, Roma, Torino
2019-10-25
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
San Giovanni Rotondo, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genova
2019-10-09
Recruiting
RECORDATI GROUP
Observational
125
Genova
2019-09-30
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Palermo, Foggia, Genova, Milan, Monza, Pavia, Roma
2019-09-23
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Foggia, Genova, Novara, Terracina
2019-09-16
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
78
Aviano, Genova, Messina, Milan, Modena, Naples, Reggio Emilia, Roma
2019-08-27
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Meldola, Rozzano, Roma, Bari, Bergamo, Candiolo, Catania, Genova
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Catania, Genova, Milan, Naples, Padova, Roma
2019-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
254
Genova, Milan, Verona, Naples
2019-07-26
Recruiting
University of Milano Bicocca
Observational
7,000
Baggiovara, Bologna, Bolzano, Carate Brianza, Ferrara, Florence, Genova, Roma
2019-07-15
Active, closed
Novo Nordisk A/S
Phase 2
62
Florence, Genova, Milan, Roma
2019-07-04
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Biella, Bolzano, Carpi, Cattolica, Faenza, Genova, Guastalla, Legnago
2019-06-14
Active, closed
Sanofi
Observational
955
Torrette Di Ancona, Terracina, Rome, Bari, Brescia, Cagliari, Genova, L’Aquila
2019-06-11
Recruiting
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
NCT03728478Oligoarthritis, Juvenile, Polyarthritis, Juvenile, Rheumatoid Factor Negative
DrugsEtanercept·Methotrexate
Istituto Giannina Gaslini
Phase 3
260
Genova
2019-05-29
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Milan, Padova, Florence, Genova, Treviso
2019-05-09
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Florence, Rome, Genova
2019-05-01
Active, closed
European Myeloma Network B.V.
Phase 2
401
Ancona, Bergamo, Bologna, Brescia, Catania, Genova, Milan, Novara
2019-04-16
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Genova, Milan, Rome, Torino
2019-03-07
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Active, closed
Exelixis
Phase 3
187
Viagrande, Catania, Meldola, Genova, Rozzano, Pisa, Torino, Milan
2018-10-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Active, closed
Marc van Sambeek
Observational
156
Genova
2018-09-11
Active, closed
Fondazione Michelangelo
Phase 3
650
Bergamo, Brindisi, Faenza, Genova, Meldola, Milan, Modena, Negrar
2018-09-07
Active, closed
Eli Lilly and Company
Phase 3
1,058
Catanzaro, Genova, Pisa, Rho, Roma, Rome, Rozzano, Torino
2018-07-18
Recruiting
Natural History of SMA
NCT05755451Muscular Atrophy, Spinal
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
1,200
Genova, Messina, Milan, Rome
2018-06-21
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Active, closed
AbbVie
Phase 3
747
Bologna, Rozzano, Milan, Rome, Negrar, Catania, Catanzaro, Genova
2018-03-21
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Recruiting
Italfarmaco
Phase 2/3
206
Genova, Messina, Milan, Roma
2017-10-24
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bari, Benevento, Bologna, Brindisi, Cagliari, Florence, Genova, Latina
2017-09-12
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Active, closed
Acerta Pharma BV
Phase 3
310
Aviano, Bergamo, Brescia, Florence, Genova, Meldola, Milan, Modena
2017-02-02
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Bari, Cuneo, Genova, Milan, Palermo, Rome, Torino, Udine
2016-12
Active, closed
Eisai Inc.
Phase 3
1,069
Faenza, Arezzo, Bologna, Genova, Lecce, Meldola, Milan, Modena
2016-10-13
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Genova, Milan, Naples, Padova, Roma, Rozzano
2016-09-13
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Genova, Milan, Torino
2016-08-03
Active, closed
Philogen S.p.A.
Phase 3
214
Genova, Milan, Padova, Naples, Siena, Trieste, Turin
2016-07-01
Active, closed
Celgene
Phase 1/2
130
Bologna, Emilia-Romagna, Florence, Genova, Orbassano, Padova, Pesaro, Roma
2016-06-03
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Bologna, Genova, Naples
2015-12
Active, closed
AstraZeneca
Phase 3
1,118
Genova, Meldola, Milan, San Giovanni Rotondo, Siena
2015-07-21
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Rozzano, Busto Arsizio, Asti, Florence, Genova, Milan, Naples, Pisa
2015-04
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Prato, Carpi, Trento, Castellanza, Aviano, Biella, Bolzano, Genova
2014-12-04
Active, closed
Eli Lilly and Company
Phase 3
453
Catania, Genova, Livorno, Parma, Rome
2014-10-03
By invitation
The Italian Multiple Sclerosis and Related Disorders Register
NCT07636876Multiple Sclerosis, Neuromyelitis Optica, Demyelinating Diseases of the Central Nervous System, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Fondazione Italiana Sclerosi Multipla
Observational
96,000
Genova
2014-09-17
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Florence, Genova, Milan
2014-06
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Observational
150
Genova
2014-05
Recruiting
Jules Bordet Institute
Not applicable
1,000
Biella, Bolzano, Carpi, Genova, Legnago, Milan, Parma, Pavia
2014-04
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
112
Alessandria, Ancona, Aviano, Biella, Bolzano, Cagliari, Catania, Genova
2013-12
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Recruiting
Italian Network MDS Registry
NCT02808858Myelodysplastic-Myeloproliferative Diseases
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
10,000
Alessandria, Ancona, Genova, Parma, Rionero in Vulture, Candiolo, Torino, Asti
2013-09
Active, closed
MedImmune LLC
Phase 2
571
Alessandria, Aviano, Bergamo, Bologna, Candiolo, Genova, Meldola, Milan
2013-05-17
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Bari, Florence, Genova, Milan, Roma, Torino
2013-03-18
Active, closed
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Recruiting
Ospedale Policlinico San Martino
Observational
100
Genova
2012-01-31
Active, closed
Fondazione del Piemonte per l'Oncologia
Observational
2,500
Aosta, Bologna, Candiolo, Genova, Milan, Orbassano, Padova, Pisa
2011-03-30
Recruiting
International (Pediatric) Peritoneal Biobank
NCT01893710Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Heidelberg University
Observational
500
Genova, Milan, Padova
2011-02-01
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
1,000
Milan, Palermo, Parma, Urbino, Bologna, Carrara, Genova, Naples
2010-09
Active, closed
AstraZeneca
Phase 2
162
Genova, Milan, Monza, Torino
2010-02-04
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Ancona, Bolzano, Brescia, Florence, Genova, Naples, Parma, Province of Macerata
2008-12-09
Recruiting
Pompe Pregnancy Sub-Registry
NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company
Observational
20
Florence, Milan, Padua, Rome, Brescia, Cagliari, Genova, Messina
2007-06-18
Active, closed
AstraZeneca
Phase 3
736
Aviano, Bergamo, Carpi, Genova, Prato, Reggio Emilia, Varese
2005-02-13
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Florence, Milan, Baggiovara, Monza, Rome, Sassari, Catania, Genova
1991-04-01
Rows per page Showing 1–483 of 483
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 October 2026. https://priyalifescience.com/clinical-trials-italy/city/genova

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 483 of those studies with a site in Genova.

How many clinical trials are recruiting in Genova?

291 of the 483 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 23 have not yet opened recruitment, 160 are active but closed to new participants, and 9 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Genova), 483 studies
PhaseStudiesRecruitingShare
Phase 320110741.6%
Observational1218625.1%
Phase 2672913.9%
Not applicable624712.8%
Phase 1/214102.9%
Phase 2/312102.5%
Phase 4621.2%

Most active sponsors

Lead sponsors with the most studies (Genova)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals218
AstraZeneca207
Eli Lilly and Company136
Bristol-Myers Squibb125
GlaxoSmithKline126
Janssen Research & Development, LLC116
Merck Sharp & Dohme LLC107
Amgen73
Daiichi Sankyo75
Meyer Children's Hospital IRCCS77
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.